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Abstract 
A novel N-acetyltransferase, Shati/Nat8l, was identified in the nucleus accumbens (NAc) of 
mice repeatedly treated with methamphetamine (METH). Shati/Nat8l has been reported to 
inhibit the pharmacological action induced by METH. Shati/Nat8l produces N-acetylaspatate 
(NAA) from aspartate and acetyl-CoA. Previously we reported that overexpression of 
Shati/Nat8l in NAc attenuates the response to METH via N-acetylaspartylglutamate (NAAG; 
which is derived from NAA)-mGluR3 signaling in the mice brain. In the present study, to 
clarify the type of cells that produce Shati/Nat8l, we carried out in situ hybridization for the 
detection of Shati/Nat8l mRNA accompanied by immunohistochemical studies using serial 
sections of mice brain. Shati/Nat8l mRNA was detected in neuronal cells, but not in astrocytes 
or microglia cells. Next, we investigated the function of Shati/Nat8l in the neuronal cells in 
mice brain; then, we used adeno-associated virus vector containing Shati/Nat8l for transfection 
and overexpression of Shati/Nat8l protein into the primary cultured neurons to investigate the 
contribution to neuronal activity of Shati/Nat8l.  Overexpression of Shati/Nat8l in the mice 
primary cultured neurons induced axonal growth but not dendrite elongation at day 1.5 (DIV). 
This finding indicated that Shati/Nat8l contributes to neuronal development. LY341495, a 
selective group II mGluRs antagonist, did not abolish this axonal growth, and NAAG itself did 
not abolish axon outgrowth in the same cultured system. The cultured neurons overexpressing 
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Shati/Nat8l contained high ATP, suggesting that axon outgrowth is dependent on energy 
metabolism. This study shows that Shati/Nat8l in the neuron may induce axon outgrowth via 
ATP synthesis and not through mGluR3 signaling. 
Key Words :  Shati/Nat8l;  NAA; NAAG; cultured neurons 
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Introduction 
Shati/Nat8l has been identified from the nucleus accumbens (NAc) of mice treated with 
methamphetamine (METH) using the PCR-based cDNA subtraction method [1]. The genetic 
locus of Shati/Nat8l is chromosome 5 (5; 5 B2), and Shati/Nat8l protein has N-acetyltransferase 
activity (Gene ID: 269642). Shati/Nat8l attenuates the pharmacological actions of 
methamphetamine, which are hyperlocomotion or conditioned place preference［2］. Further, 
Shati/Nat8l is also related to the lipid turnover and energy expenditure in brown adipocytes in 
mice [3]. Shati/Nat8l produces N-acetylaspatate (NAA) from aspartate and acetyl-CoA in 
central nervous system [4, 5].  NAA is expressed in the neurons at relatively high 
concentrations, and its level is decreased in patients with psychiatric disorders, such as 
schizophrenia, Alzheimer's disease, depression, and autism [6, 7, 8]. NAA is used by 
N-acetylaspartylglutamate (NAAG) synthetase to produce NAAG, a highly selective 
endogenous metabotropic glutamate receptor (mGluR) 3 agonist [9, 10]. mGluRs is considered 
to be a key receptor to clarify the physiological roles of Shati/Nat8l [9, 10]. Previously we 
reported that overexpression of Shati/Nat8l in the NAc attenuates the response to METH via the 
action of NAAG increment in mice [2]. NAA is metabolized to aspartate and acetyl-CoA by 
aspartoacylase, and then acetyl-CoA is converted to acetate for lipid synthesis in the 
oligodendrocytes [11]. NAA is produced in the mitochondria and is associated with the TCA cycle 
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[12]. In the mitochondria, oxaloacetate and glutamate are converted to aspartate and α-ketoglutarate 
by aspartate amino transferase, and while aspartate is being converted to NAA by 
N-acetyltransferase, α-ketoglutarate can enter the TCA cycle. Although there are many reports 
about NAA, the method of localization and function of Shati/Nat8l in neurons remains unclear. 
A review paper reported two patterns of localization of Shati/Nat8l in the brain [13]. First, 
Myc-tagged-Shati/Nat8l was transfected to cultured Chinese hamster ovary (CHO) cells and 
primary cultured neurons, which showed that Shati/Nat8l localized in the endoplasmic 
reticulum [4]. Alternatively, Ariyannur et al. (2010) showed that Shati/Nat8l was expressed in 
the mitochondria of neurons. From aforementioned results, the role of Shati/Nat81 in the neuronal 
systems could not be conclusively elucidated. To investigate the same, we used a different approach, 
to clarify the main role of Shati/Nat8l in the neuronal system. 
In the present study, we transfected an adeno-associated virus (AAV) vector containing 
Shati/Nat8l into the primary cultured neurons. Overexpression of Shati/Nat8l in primary 
cultured neurons induced axonal growth but not dendrite elongation. The treatment with 
LY341495, a selective group II mGluRs antagonist, did not cancel Shati/Nat8l-induced axon 
outgrowth, and NAAG itself did not induce axon outgrowth. Overexpression of Shati/Nat8l also 
increased the ATP content in neurons. These results suggest that neuronal Shati/Nat8l induces 
axon outgrowth via ATP synthesis independently of mGluR3 signaling pathway. 
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Materials and Methods 
Animals 
The experiments were performed using mice (8 weeks old) and mice embryos (embryonic 
day 15) of the ICR strain (SLC, Japan). The animals were housed in a room with 12 h light/dark 
cycles (light cycle starting at 8:00 AM.).  Food and water were available ad libitum. All 
experiments followed the National Institute of Health Guidelines for the Care and Use of 
Laboratory Animals and were approved by the committee for Animal Experiments of the 
University of Toyama. 
 
In situ hybridization and immunostaining of mice brains 
The mice were anesthetized with a lethal dose of sodium pentobarbital (50 mg/kg i.p.) and 
perfused through the left ventricle, first with 50 ml of phosphate-buffered saline (PBS) to flush 
the blood vessels quickly, followed by 50 ml of cold PBS containing 4% paraformaldehyde 
(PFA).  The brains were removed, post-fixed in 4% PFA at 4°C overnight, followed by 
overnight cryoprotection in 30% sucrose with PBS at 4°C. The brain sections (14 μm) were 
treated with digoxigenin (DIG)-labeled Shati/Nat8l antisense riboprobes (accession no. 
NM_001001985; nucleotides [2033 – 2845]). After hybridization, the sections were incubated 
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with anti-DIG-AP Fab fragments. After washing, the sections were treated with nitro blue 
tetrazolium chloride (NBT)/5-bromo-4-chloro-3-indolyl-phosphate (BCIP). In the 
pre-experiments, we did in situ hybridization using the brain slices of Shati/Nat8l knock out 
mice, any positive signal was not observed (data not shown). 
Primary antibodies were NeuN (1:200; MAB377, Millipore, USA), GFAP (1:200; 3670, 
Cell Signaling Technology, USA), and Iba1 (1:200; 019-19741, Wako, Japan). Secondary 
antibodies were CFTM488 goat anti-mouse IgG (H + L) (1:1000; 20018, Biotium, USA) and 
CFTM594 goat anti-rabbit IgG (H + L) (1:1000; 20113, Biotium). 
 
Primary culture of hippocampal and cortical neurons and immunostaining 
Neurons were prepared from the hippocampus and cortex of fetuses from female mice on day 
15 of gestation, as previously described [14]. The cultured neurons were fixed with PFA in PBS 
and permeabilized with 0.1% Triton, and 3% normal goat serum (NGS; G9023) in PBS. The 
cells were incubated overnight with a primary antibody [anti microtubule associated protein 2 
(MAP2) (1:1000; M4403, Sigma), and anti-green fluorescence protein (GFP) (1:1000; ab6556, 
Abcam), and anti-Tau-1 (1:1000; Millipore)] in PBS containing 2% NGS at 4°C. The cells were 
subsequently incubated with CFTM594 goat anti-mouse IgG (1:1000; 20111, Biotium) or 
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CFTM488 goat anti-rabbit IgG (1:1000; 20019, Biotium) in PBS containing 2% NGS for 2 h at 
room temperature.  
 
Measurement of the axon outgrowth and the dendrite elongation  
The measurement of the axon outgrowth and the dendrite elongation was taken with 
modifications, as previously described [15]. After the cultured neurons were incubated for 1 h at 
37°C, half of the medium was changed to D-MEM containing 0.2% (v/v) AAV-vector. The 
production of AAV vector was previously described [2]. We selected the experimental schedule 
described by Carlos [15]. To assess the axon outgrowth and dendrite elongation, the neurons 
were co-immunostained with anti-GFP and anti-Tau-1 antibodies at DIV 1.5 and with anti-GFP 
and anti-MAP2 antibodies at DIV 4, respectively. We randomly evaluated three different GFP 
positive cells per dish and considered their average to represent the score of the cultured dish. 
Each group was tested using 5 dishes in one experiment.  We selected the doses of NAAG and 
LY341495, a selective group II mGluRs antagonist, following previously reports [16, 17]. 
 
Quantitative RT-PCR and measurement of NAA and NAAG 
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Quantitative RT-PCR was performed as previously described [2]. The measurement of NAA and 
NAAG by high performance liquid chromatography (HPLC) was performed as previously 
described [2]. 
 
Measurement of ATP contents 
To measure the ATP contents during axon outgrowth, the neurons were collected in cold PBS at 
DIV1.5. ATP contents were measured according to the instructions of ATP assay kit (Abcam, 
USA). 
 
 Statistical Analyses 
All data were expressed as the mean ± standard error of mean (S.E.M.). Statistical differences 
between the two groups were determined with a Student-t test. Statistical differences among the 
values for individual groups were determined by analysis of variance (ANOVA) followed by 
Bonferroni’s post-hoc test (Prism version 5). 
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Results 
Shati/Nat8l mRNA expression in mice whole brain and neuronal cells. 
We investigated Shati/Nat8l mRNA expression in the mouse brain using in situ hybridization 
(Figure 1).  Shati/Nat8l mRNA signal was observed any brain regions investigated in this study.  
Especially, the strong signals were detected in the cortical pyramidal cells, dentate granule cells, 
hippocampal pyramidal cells and cerebellar granule cells. Neuronal cells of all brain regions 
were Shati/Nat8l mRNA positive. We chose to focus on the hippocampus because it contains 
many kind of cells, it is easy to evaluate, and it has high cell density. Hippocampus serial 
sections were used for both in situ hybridization and immunohistochemistry with neuronal and 
glial cell markers (Figure 1). Shati/Nat8l mRNA positive cells colocalized with NeuN (a marker 
of neuron) positive cells but not with GFAP (a marker of astrocyte) or Iba1 (a marker of 
microglia) positive cells. This result shows that Shati/Nat8l mRNA is only expressed in the 
neuronal cells of the mouse brain. 
 
Overexpression of Shati/Nat8l affects axonal growth but not dendrite elongation of 
primary cultured neurons. 
To validate neuronal function of Shati/Nat8l, we measured dendrite elongation and axon 
outgrowth in the cultured Shati/Nat8l overexpressed neurons, since they indicate the important 
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role of neuronal development. We used the marker protein MAP2 for dendrite elongation 
evaluation (Figure 2a) and Tau-1 for axon outgrowth evaluation (Figure 2b). There was a 
significant difference in the axonal length between neurons overexpressing Shati/Nat8l and 
controls (t14 = 5.722, p < 0.05) (Figure 2c). There were no differences in the total dendrite 
length (t14 = 0.3095, n.s.), dendrite length (t14 = 0.3547, n.s.), number of processes (t14 = 1.144, 
n.s.), and number of brunch points (t14 = 1.602, n.s.) between Shat/Nat8l overexpressed neuron 
and mock neuron (Figure 2d-g). These results show that Shati/Nat8l induces axon outgrowth but 
not dendrite elongation in primary cultured neurons. 
 
mGluR3 signaling has no effect on Shati/Nat8l-induced axon outgrowth of primary cultured 
neurons. 
To investigate the contribution of group II mGluR3 signaling on Shati/Nat8l-induced axon 
outgrowth, we used NAAG and LY341495, a selective group II mGluRs antagonist for the 
cultured neurons as previously described [15, 16]. Figure3 showes that LY341495 does not 
affect Shati/Nat8l-induced axon outgrowth (Mock vs Shati/Nat8l, F 3,56 = 5.659, p < 0.001 ; 
Shati/Nat8l vs Shati/Nat8l + LY, F3,56 = 1.605, n.s.) (Figure 3a, right two columns). To test 
whether NAAG also induces axon outgrowth, we exposed the cultured neurons to NAAG.  
 13 
Figure 3b shows that NAAG does not induce axon outgrowth (Control vs NAAG 100 µM, F3,45 
= 19.76, n.s.). These results suggest that mGluR3 signaling does not affect axon outgrowth. 
 
Overexpression of Shati/Nat8l in cultured neurons increased the ATP content 
Since it is proposed that NAA synthesis is involved in mitochondrial function [5], we 
measured the contents of NAA and ATP in cultured neurons. Shati/Nat8l mRNA levels 
increased 2.3 ± 0.34 folds in the AAV-Shati/Nat8l neurons compared to the AAV-Mock neurons 
(Figure 3c, t4 = 5.502, p < 0.05). Shati/Nat8l increased the content of ATP in the cultured 
neurons (Figure3d, t4 = 5.431, p < 0.01). The level of NAA in AAV-Shati/Nat8l neurons was 
significantly higher than in AAV-Mock neurons (Figure 3e, t2 = 4.419, p < 0.05), whereas there 
was no difference in NAAG level between these neurons (Figure 3f, t2 = 1.855, n.s). These 
results suggest that Shati/Nat8l is involved in the mitochondrial function via NAA synthesis. 
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Discussion 
The present study demonstrates that Shati/Nat8l is expressed in neuronal cells in every region 
of the mouse brain (Figure 1a) and induces axon outgrowth accompanied with ATP increment. 
The finding that Shati/Nat8l mRNA is expressed in neuronal cells suggests that Shati/Nat8l has 
a functional role in the brain (Figure 1a and b). We demonstrated that overexpression of 
Shati/Nat8l in neurons induced axon outgrowth but not dendrite elongation (Figure 2c). 
Moreover, LY341495 is unable to abolish the Shati/Nat8l induced-axon outgrowth, and NAAG 
didn’t induce axon outgrowth by itself (Figure 3b). Overexpression of Shati/Nat8l increases ATP 
content in neurons (Figure 3d). Therefore, Shati/Nat8l in the neuron may be associated with the 
ATP synthesis pathway. 
We previously reported that Shati/Nat8l is associated with the microtubule structure using 
Shati/Nat8l overexpression in COS7 cells and mice primary cultured neurons [18]. On the other 
hand, it was also reported that Shati/Nat8l colocalizes with the mitochondrial marker in 
SH-SH5Ycells [5], and that Shati/Nat8l is localized in the endoplasmic reticulum [4]. Thus, the 
localization of Shati/Nat8l required further clarification. Therefore, in the present study, we used 
a new method “AAV-vector expressing Shati/Nat8l” to clarify the novel and main functions of 
Shati/Nat8l in the neuronal cells. 
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NAA is predicted to be produced in the mitochondria because it is associated with the TCA 
cycle related to the metabolism in the cell [12]. Here, we showed that overexpression of 
Shati/Nat8l increases the levels of NAA and ATP in primary cultured neurons. The TCA cycle 
produces ATP molecules at the highest rate in terms of cell metabolism, and ATP in the growth 
cone is known to promote neurite elongation in cultured neurons [19]. Neuronal dendrite 
lengths of Shati/Nat8l knock-out mice were significantly short compared with those of the 
wild-type mice [16]. Taken together, Shati/Nat8l appears to play a major role in ATP 
induced-neurite elongation. Shati/Nat8l is an indicator for the stimulation of mGluR3. However, 
neither NAAG nor Ly341495, the endogenous agonist of mGluR3 and an antagonist of mGluR3, 
respectively, affected axon outgrowth. Therefore, Shati/Nat8l is associated with neurite 
elongation and ATP synthetic pathway via its function in NAA synthesis. 
In conclusion, we show a unique neuronal function of Shati/Nat8l in AAV-vector harboring 
Shati/Nat8l cDNA to overexpress Shati/Nat8l in the neuron, we are able to show that 
Shati/Nat8l induces axon outgrowth with increases in ATP content in the absence of mGluR3 
pathway activation. These results suggest that Shati/Nat8l is associated with axon outgrowth via 
the ATP synthetic pathway via its function in NAA synthesis. Role of NAA in the brain function 
is not clear, although NAA level is decreased in patients with various psychiatric disorders [6, 7, 
8]. Further investigation of the Shati/Nat8l could provide new insights into the roles of 
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Shati/Nat8l and NAA in the brain function. Shati/Nat8l and/or NAA might be new target of the 
clinical stratagem for neuronal and psychiatric diseases. Especially NAA would be one of 
indicators of neuronal activity and function in brains. 
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Figure legends 
Figure 1.  Shati/Nat8l mRNA is expressed in the neuronal cells of the mouse brain. 
(a,b) In situ hybridization analyses show the expression pattern of Shati/Nat8l mRNA in the 
mouse brain. The small figure shows the positive-cells in detail. (b - e) NeuN, GFAP, and Iba1 
were detected in the same brain region by the immunostaining. Scale bars: in the large figure = 
500 μm, in the small figure = 50 μm 
 
Figure 2. Overexpression of Shati/Nat8l in the neuron induces axon outgrowth but not 
dendrite elongation. 
(a) The neurons were infected with AAV-Mock or AAV-Shati/Nat8l 1 h after the culture was 
started, and Tau-1 immunostaining shows the morphology of neuronal axons at 1.5 DIV.  GFP 
positive-cells correspond to neurons transfected with the AAV-vector. (b) Quantitative analysis 
shows that overexpression of Shati/Nat8l increases axon length at 1.5 DIV (n = 5 dishes for 
each group). (c) MAP2 immunostaining shows the morphology of the neuronal dendrites at 4 
DIV.  GFP positive-cells correspond to neurons transfected with the AAV-vector. (d-g) 
Dendritic length, total neurite length, the number of processes, and the number of branch points 
per neuron were analyzed. No effects were observed in the total dendrite length, dendrite length, 
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the number of processes, and the number of branch points by overexpression of Shati/Nat8l. n = 
5 dishes for each group, *p < 0.05 vs AAV-Mock (Student’s t-test). 
 
Figure 3. mGluR3 signaling is not needed for Shati/Nat8l-induced axon outgrowth of 
cultured neurons. 
(a) The neurons infected with AAV-Mock or AAV-Shati/Nat8l were treated with 100 µM 
LY341495 1h after infection with the AAV vector. Tau-1 and GFP were stained at 1.5 DIV. GFP 
positive-cells correspond to neurons transfected with the AAV-vector. Quantitative analysis 
showes that inhibition of mGluR3 with 100 µM LY341495 does not affect Shati/Nat8l-induced 
axon outgrowth. n = 5 dishes for each group, **p < 0.01 vs. AAV-Mock, ***p < 0.001 vs. 
AAV-Mock (ANOVA with repeated measures followed by the Bonferroni’s post-hoc test). (b) 
The neurons were treated with NAAG 2 h after the culture was started. Quantitative analysis 
shows that activation of mGluR3 with NAAG does not affect Shati/Nat8l-induced axon 
outgrowth. n = 5 dishes for each group. (c) Expression levels of Shati/Nat8l mRNA in the 
AAV-Mock and AAV-Shati/Nat8l neurons were measured at 1.5 DIV. n = 3 dishes for each 
group, *p < 0.05 vs. AAV-Mock (Student’s t-test). (d) The ATP content in the neuron was 
analyzed at 1.5 DIV. Quantitative analysis shows that overexpression of Shati/Nat8l 
significantly increases the ATP content compared with Mock. n = 5 dishes for each group, **p < 
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0.01 vs AAV-Mock (Student’s t-test). (e, f) The contents of NAA (e) and NAAG (f) in the 
AAV-Mock and AAV-Shati/Nat8l neurons were compared using HPLC at 1.5 DIV. n = 3 dishes 
for each group. *p < 0.05 vs. AAV-Mock (Student’s t-test). 
 
